ACUTA CAPITAL PARTNERS, LLC FDMT 4D MOLECULAR THERAPEUTICS IN

Ownership history in ACUTA CAPITAL PARTNERS, LLC  ·  5 quarters on record

AI Ownership Summary

ACUTA CAPITAL PARTNERS, LLC reported 4D MOLECULAR THERAPEUTICS IN (FDMT) in 5 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 1.59% in 2026 Q1. The latest visible filing shows FDMT at 1.59% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this FDMT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was ACUTA CAPITAL PARTNERS, LLC's position in 4D MOLECULAR THERAPEUTICS IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

FDMT was reported at 1.59% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.59% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How ACUTA CAPITAL PARTNERS, LLC held FDMT — position size vs. price
% of Fund (quarterly)    FDMT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 2 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 242,255 +167,755 +225.2% 1.59% $2.3M 2026-05-15 $9.15
2023 Q4 REDUCED 28.9% +48.1% 74,500 -30,253 -28.9% 0.85% $1.5M 2024-02-14 $27.81
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About ACUTA CAPITAL PARTNERS, LLC and FDMT

These are the practical questions this page is built to answer before you even open the full history table.

How long has ACUTA CAPITAL PARTNERS, LLC reported owning FDMT?

ACUTA CAPITAL PARTNERS, LLC reported FDMT across 2 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported FDMT position in ACUTA CAPITAL PARTNERS, LLC's portfolio?

The largest reported portfolio weight for FDMT was 1.59% in 2026 Q1.

What is the latest reported FDMT position on this page?

The most recent filing on this page is 2026 Q1, when ACUTA CAPITAL PARTNERS, LLC reported 242,255 shares, equal to 1.59% of portfolio, with an estimated market value of $2.3M.

What does the chart on this FDMT ownership page compare?

The chart compares ACUTA CAPITAL PARTNERS, LLC's quarterly FDMT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did ACUTA CAPITAL PARTNERS, LLC time their FDMT position?

Based on 13F filing dates vs. subsequent FDMT price moves, ACUTA CAPITAL PARTNERS, LLC correctly timed 2 out of 3 reported position changes (67%).

← Back to ACUTA CAPITAL PARTNERS, LLC Holdings